Irene Moreno-Candilejo
11PUBLICATIONS
143CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Mar 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.Maria Vieito, Elisa Fontana, Catherine H Han
|Mar 13, 2026
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer.Francois Ghiringhelli, Richard Kim, Teresa Macarulla
|Aug 11, 2025
Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.Richard D Baird, Begoña Bermejo de Las Heras, Manuel Ruiz-Borrego
|Mar 17, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.Johann S de Bono, Anja Williams, Ignacio Melero
|Feb 25, 2025
Author Correction: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco
Pageof 2
Frequent Collaborators
4 joint publications
Ignacio Melero
4 joint publications
Emiliano Calvo
4 joint publications
Reinhard Dummer
2 joint publications
Jorge Esteban-Villarrubia
2 joint publications
Kira-Lee Koster
2 joint publications
Tatiana Hernandez
2 joint publications
Juan José Soto-Castillo
2 joint publications
Paula Sabat
2 joint publications
Martin Schuler
2 joint publications
Elena Garralda